You are here

  • Home
  • Archive
  • Volume 31, Issue Suppl 4
  • EPV107/#258 ENGOT-EN11/GOG-3053/KEYNOTE-B21: phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer

Article metrics

Article menu

Download PDFPDF

E-Posters
E-Poster Viewing
EPV107/#258 ENGOT-EN11/GOG-3053/KEYNOTE-B21: phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to September 2024

AbstractFullPdf
Nov 202165021
Dec 20211806
Jan 20223207
Feb 20221801
Mar 20224105
Apr 20221604
May 20222208
Jun 20221205
Jul 20221604
Aug 20224608
Sep 20222009
Oct 202225011
Nov 20223806
Dec 20222506
Jan 20231605
Feb 20231200
Mar 20231402
Apr 20231404
May 20231007
Jun 2023904
Jul 20231203
Aug 20232602
Sep 20231203
Oct 20232003
Nov 20232705
Dec 20234401
Jan 20242601
Feb 20241405
Mar 20242706
Apr 20242404
May 20242203
Jun 20241804
Jul 20241104
Aug 20241708
Sep 20241800
Total7870175